Home ADNKronos Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform
 

Immediapress

Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

 

(Adnkronos) - 6 Clinical Posters and a Presentation Including New Results of a 1,447 Patient Study Highlights the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Applications TORONTO and PHILADELPHIA, Sept. 21, 2023 /PRNewswire/ --

I contenuti di VeneziePost sono a pagamento.
Per visualizzare questo articolo e tutti i nostri contenuti scegli tra queste opzioni
Sei già iscritto a VeneziePost?
Clicca qui sotto e inserisci le tue credenziali
Accedi
Facebook Twitter Linkedin Email